Evidence map›Paper›PMID 34589370›Full record

ReviewCureus2021

Understanding Seizures and Prognosis of the Extreme Delta Brush Pattern in Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis: A Systematic Review.

Jashank Parwani, Juan Fernando Ortiz, Ammar Alli, Ayushi Lalwani, Samir Ruxmohan, Hyder Tamton, Victor D Cuenca, Dina Gonzalez, Fatima Anwer, Ahmed Eissa-Garcés and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Jashank ParwaniNeurology, Lokmanya Tilak Municipal Medical College, Mumbai, IND.
Juan Fernando OrtizNeurology, Universidad San Francisco de Quito, Quito, ECU.
Ammar AlliMedicine, Tishreen University Faculty of Medicine, Lattakia, SYR.
Ayushi LalwaniInternal Medicine, KJ Somaiya Medical College, Mumbai, IND.
Samir RuxmohanNeurology, Larkin Community Hospital, Miami, USA.
Hyder TamtonNeurology, Larkin Community Hospital, Miami, USA.
Victor D CuencaMedicine, Universidad San Francisco de Quito, Quito, ECU.
Dina GonzalezMedicine, Universidad del Sinu, Cordova, COL.
Fatima AnwerNeurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ahmed Eissa-GarcésNeurology, Universidad San Francisco de Quito, Quito, ECU.
Ivan Mateo AlzamoraMedicine, Universidad San Francisco de Quito, Quito, ECU.
Maria PaezGeneral Medicine, Pontificia Universidad Catolica del Ecuador, Quito, ECU.
Universidad San Francisco de Quito · ECLarkin Community Hospital · USCalifornia Institute of Behavioral Neurosciences and Psychology (United States) · USLokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College · INUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis (ANMDARE) is an autoimmune disorder with neurological and psychiatric features. The disease presents with a viral prodrome, followed by psychiatric manifestations. In the next phase, movement disorders or/and seizures occur. Finally, in the last phase, there is a decrease in the level of consciousness. Central hypoventilation and autonomic dysfunction can occur. Recently a unique EEG (electroencephalogram) pattern has been associated with anti-NMDA receptor encephalitis, the extreme delta brush (EDB). Although the association of the EDB with ANMDARE is known by the medical community, its significance is mainly unknown. A systematic review on NMDARE is also scarce. We decided to conduct a systematic review on this topic to consolidate the knowledge and establish the importance of the EDB as a prognostic factor. To conduct this systematic review, we used only studies conducted in humans, written in English, and published in the last 20 years. We used PubMed as a database and searched the following search terms: ("NMDA encephalitis"[Title/Abstract] AND "Epilepsy"[Title/Abstract]) OR (NMDA encephalitis"[Title/Abstract] AND "seizures" [Title/Abstract]) OR ("NMDA encephalitis"[Title/Abstract] AND "extreme delta brush"[Title/Abstract]). The protocol used for this systematic review was the Meta-analyses Of Observational Studies in Epidemiology (MOOSE) protocol, and to analyze the bias of the studies, we used the ROBINS-1 tool. Eight studies were collected from our search strategy. Our data pulling showed that seizures were present in 178/249 (71.48%) patients. Status Epilepticus was reported in 29/96 (30.20%), and the EBD was seen in 30.89% (55/178) patients with seizures. The range of EDB was 5.9%-33% among the studies. Because the sample size was small, the statistical power was decreased. We had a low overall risk of bias. The wide range in the results could be related to the timing of the EEG recording. EDB was associated overall with increased length of hospital stay, increased ICU admission, and incidence of status epilepticus. The etiology of the EDB remains mainly unknown. However, it has been postulated that in NMDAR encephalitis, there is a disruption of the rhythmic neuronal activity. When antibodies block/target the NMDAR, the rhythmic neuronal activity is disrupted, leading to the unique EDB pattern. Another theory suggests that delta activity is caused because of focal abnormalities in the brain, and the superimposition of the beta waves is related to the alterations of the NMDA receptors.

Indexed as

anmdareencephalitisepilepsyextreme delta brushmovement disordernmdapartial epilepsy

Identifiers

PMID34589370
PMCPMC8460549
OpenAlexW3200890600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.